Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies

키워드

참고문헌 (77)

1. World Alzheimer Report 2010: the global economic impact of dementia, "Wimo A", Alzheimer’s Disease International, 1~56 (2010)
2. Cummings JL., "Alzheimer's disease", N Engl J Med, 351, pp.56~67 (2004)
3. Osborn GG, "Current treatments for patients with Alzheimer disease", J Am Osteopath Assoc, 110(9Suppl 8), pp.S16~S26 (2010)
4. Huang Y, "Alzheimer mechanisms and therapeutic strategies", Cell, 148, pp.1204~1222 (2012)
5. Li JW, "Drug discovery and natural products:end of an era or an endless frontier?", Science, 325, pp.161~165 (2009)
6. Ohizumi Y., "Application of physiologically active substances isolated from natural resources to pharmacological studies", Jpn J Pharmacol, 73, pp.263~289 (1997)
7. Nagase H, "Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities", Biochem Biophys Res Commun, 337, pp.1330~1336 (2005)
8. Nagase H, "Mechanism of neurotrophic action of nobiletin in PC12D cells", Biochemistry, 44, pp.13683~13691 (2005)
9. Matsuzaki K, "Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus", Eur J Pharmacol, 578, pp.194~200 (2008)
10. Auld DS, "Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies", Prog Neurobiol, 68, pp.209~245 (2002)
11. Schliebs R, "The cholinergic system in aging and neuronal degeneration", Behav Brain Res, 221, pp.555~563 (2011)
12. Hozumi S, "Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy", Behav Brain Res, 138, pp.9~15 (2003)
13. Yamamoto T, "Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs", Behav Brain Res, 83, pp.57~62 (1997)
14. Bobkova NV, "Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer's disease", J Alzheimers Dis, 38, pp.425~435 (2014)
15. Peters JM, "Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques", Am J Psychiatry, 160, pp.1995~2002 (2003)
16. Djordjevic J, "Olfaction in patients with mild cognitive impairment and Alzheimer's disease", Neurobiol Aging, 29, pp.693~706 (2008)
17. Nakajima A, "Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice", J Pharmacol Sci, 105, pp.122~126 (2007)
18. Heckers S, "Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor", J Neurosci, 14, pp.1271~1289 (1994)
19. Tarricone BJ, "Intrahippocampal transplants of septal cholinergic neurons: choline acetyltransferase activity, muscarinic receptor binding, and spatial memory function", Brain Res, 632, pp.41~47 (1993)
20. Hardy J, "The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics", Science, 297, pp.353~356 (2002)
21. Van Dam D, "Animal models in the drug discovery pipeline for Alzheimer's disease", Br J Pharmacol, 164, pp.1285~1300 (2011)
22. Nitta A, "beta-Amyloid protein-induced Alzheimer's disease animal model", Neurosci Lett, 170, pp.63~66 (1994)
23. Yamada K, "Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats", Br J Pharmacol, 128, pp.419~427 (1999)
24. Matsuzaki K, "Nobiletin restoring beta-amyloidimpaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats", Neurosci Lett, 400, pp.230~234 (2006)
25. Onozuka H, "Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease", J Pharmacol Exp Ther, 326, pp.739~744 (2008)
26. Shin RW, "Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau", Acta Neuropathol, 113, pp.627~636 (2007)
27. Das SR, "Changes in expression of splice cassettes of NMDA receptor GluN1 subunits within the frontal lobe and memory in mice during aging.", Behav Brain Res, 222, pp.122~133 (2011)
28. Brim BL, "Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor", Behav Brain Res, 238, pp.211~226 (2013)
29. Huang YJ, "NMDA neurotransmission dysfunction in behavioral and psychological symptoms of Alzheimer's disease", Curr Neuropharmacol, 10, pp.272~285 (2012)
30. Mishizen-Eberz AJ, "Biochemical and molecular studies of NMDA receptor subunits NR1", 2A, Neurobiol Dis, pp.2004, 15[DOI]
31. Sze C, "N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease", J Neurol Sci, 182, pp.151~159 (2001)
32. MK-801 binding in Alzheimer's disease, "J Neurochem", 1989, 698~704
33. Snyder EM, "Regulation of NMDA receptor trafficking by amyloid-beta", Nat Neurosci, 8, pp.1051~1058 (2005)
34. Nakajima A, "Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signalregulated kinase signaling", J Pharmacol Exp Ther, 321, pp.784~790 (2007)
35. Cammarota M, "Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade", Brain Res Mol Brain Res, 76, pp.36~46 (2000)
36. Alonso M, "Aversive experiences are associated with a rapid and transient activation of ERKs in the rat hippocampus", Neurobiol Learn Mem, 77, pp.119~124 (2002)
37. Sagare AP, "Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease", Cold Spring Harb Perspect Med, 2 (2012)[DOI]
38. Wang X, "Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats", J Alzheimers Dis, 21, pp.813~822 (2010)
39. Yamamoto Y, "Nobiletin improves brain ischemiainduced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation", Brain Res, 1295, pp.218~229 (2009)
40. Takeda T., "Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8and SAMP10 mice", Neurochem Res, 34, pp.639~659 (2009)
41. Butterfield DA, "The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease", Exp Gerontol, 40, pp.774~783 (2005)
42. Tomobe K, "Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence", Neurochem Res, 34, pp.660~669 (2009)
43. Nakajima A, "Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse", Behav Brain Res, 250, pp.351~360 (2013)
44. Phillips RG, "Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning", Behav Neurosci, 106, pp.274~285 (1992)
45. Ohta A, "Deterioration in learning and memory of fear conditioning in response to context in aged SAMP8 mice", Neurobiol Aging, 22, pp.479~484 (2001)
46. Sakurai T, "Involvement of leucine zipper transcription factor-like protein 1 (Lztfl1) in the attenuation of cognitive impairment by exercise training", Biochem Biophys Res Commun, 416, pp.125~129 (2011)
47. LaBar KS, "Cognitive neuroscience of emotional memory", Nat Rev Neurosci, 7, pp.54~64 (2006)
48. Sartori SB, "Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions", PLoS One, 6, pp.e16849~ (2011)
49. Markesbery WR., "Oxidative stress hypothesis in Alzheimer's disease", Free Radic Biol Med, 23, pp.134~147 (1997)
50. Nomura Y, "Biochemical changes related to aging in the senescenceaccelerated mouse", Exp Gerontol, 24, pp.49~55 (1989)
51. Butterfield DA, "Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alphaphenylnitrone", Proc Natl Acad Sci U S A, 94, pp.674~678 (1997)
52. Okatani Y, "Melatonin reduces oxidative damage of neural lipids and proteins in senescence-accelerated mouse", Neurobiol Aging, 23, pp.639~644 (2002)
53. Nemoto K, "Characteristics of nobiletin-mediated alteration of gene expression in cultured cell lines", Biochem Biophys Res Commun, 431, pp.530~534 (2013)
54. Ikeda A, "Suppressive effect of nobiletin, a citrus polymethoxyflavonoid that downregulates thioredoxin-interacting protein expression, on tunicamycin-induced apoptosis in SK-N-SH human neuroblastoma cells", Neurosci Lett, 549, pp.135~139 (2013)
55. Su JD, "3',4'-didemethylnobiletin induces phase II detoxification gene expression and modulates PI3K", Akt signaling in PC12cells, 2012, 126~141
56. Lu YH, "Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide", Neurosci Lett, 484, pp.6~11 (2010)
57. Goedert M, "A century of Alzheimer's disease", Science, 314, pp.777~781 (2006)
58. Bramblett GT, "Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding", Neuron, 10, pp.1089~1099 (1993)
59. Johnson GV, "Tau phosphorylation in neuronal cell function and dysfunction", J Cell Sci, 117, pp.5721~5729 (2004)
60. Han D, "Familial FTDP-17missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro", J Biol Chem, 284, pp.13422~13433 (2009)
61. Cho JH, "Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules", J Neurochem, 88, pp.349~358 (2004)
62. Goedert M, "The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development", Proc Natl Acad Sci USA, 90, pp.5066~5070 (1993)
63. Morishima-Kawashima M, "Proline-directed and non-proline-directed phosphorylation of PHF-tau", J Biol Chem, 270, pp.823~829 (1995)
64. Rudrabhatla P, "Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs", FASEB J, 25, pp.3896~3905 (2011)
65. Arriagada PV, "Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease", Neurology, 42, pp.631~639 (1992)
66. Berg L, "Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype", Arch Neurol, 55, pp.326~335 (1998)
67. Giannakopoulos P, "Pathological substrates of cognitive decline in Alzheimer's disease", Front Neurol Neurosci, 24, pp.20~29 (2009)
68. Cui Y, "Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation", Biol Pharm Bull, 33, pp.1814~1821 (2010)
69. Pardridge WM., "Alzheimer's disease drug development and the problem of the blood-brain barrier", Alzheimers Dement, 5, pp.427~432 (2009)
70. Saigusa D, "High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound", Anal Bioanal Chem, 400, pp.3635~3641 (2011)
71. Asakawa T, "PET imaging of nobiletin based on a practical total synthesis", Chem Commun (Camb), 47, pp.2868~2870 (2011)
72. Yasuda T, "Urinary metabolites of nobiletin orally administered to rats", Chem Pharm Bull (Tokyo), 51, pp.1426~1428 (2003)
73. Li S, "Identification of nobiletin metabolites in mouse urine", Mol Nutr Food Res, 50, pp.291~299 (2006)
74. Al Rahim M, "4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA", ERK, Biochemistry, pp.2009, 48[DOI]
75. Lee J, "Target deconvolution techniques in modern phenotypic profiling.", Curr Opin Chem Biol, 17, pp.118~126 (2013)
76. Futamura Y, "Target identification of small molecules based on chemical biology approaches.", Mol Biosyst, 9, pp.897~914 (2013)
77. Seki T, "Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer's disease: a case series", Geriatr Gerontol Int, 13, pp.236~238 (2013)

관련 논문AI추천